drugset / Trial / NCT06358313

Concomitant Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Small Vessel Stroke

NCT06358313

Phase 3 Recruiting 600 enrolled Kafrelsheikh University
RandomizedParallel-groupDouble-blindTreatment

Summary

Along with the current clinical trial, the impact of adding atorvastatin or rosuvastatin in the first 24 hours on the clinical outcomes of first-ever small vessel stroke patients treated with clopidogrel and aspirin assessed through NIHSS, mRS, and possible adverse effects.

Timeline

Start
2024-04-10
Primary completion
2026-05-10
Completion
2026-05-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Atorvastatin Small molecule 40 mg
Comparator Rosuvastatin Small molecule 20 mg
Comparator Clopidogrel Small molecule 75 mg

Indications